mercredi 4 juillet 2018

Onco Actu du 4 juillet 2018

4.2 Dép., diag. & prono. - Génome

Routine DNA tests will put NHS at the 'forefront of medicine' [The Guardian]

4.7 Dép., diag. & prono. - Col de l'utérus

For Women Over 30, There May Be A Better Choice Than The Pap Smear [NPR]

HPV test is better than Pap smear at detecting precancerous cervical changes, study says [Washington Post]

HPV test tops Pap smear in cancer screening study [CNN]

4.9 Dép., diag. & prono. - Sein

Breast cancer surgeons don't always order genetic testing for patients [Reuters]

5.1 Traitements - Pré-clinique

New ‘triple therapy’ could boost treatment and prevent relapse of advanced breast cancer [Institute of Cancer Research]

5.12.2 Immunothérapies - CAR-T, thérapies cellulaires

Nanoparticles open doors to cancer-fighting CAR T cells [Fred Hutch]

5.12.6 Immunothérapies - AMM

FDA Limits the Use of Tecentriq and Keytruda [RAPS]

5.2.1 Pharma - Partenariats

Novartis dumps Aveo drug as relationship sours [FierceBiotech]

Priority Changes for Novartis Spell the End for Aveo Pharma Alliance [Xconomy]

5.4 Traitements - Economie

NICE says Tookad too expensive for prostate cancer [PharmaTimes]

Drugmakers defy Trump's call to drop prices [Politico]

6.1 Observation

Where childhood cancer hits hardest [CNBC]

6.10 Politiques

China to reduce cancer drug prices [Xinhua]

6.7.1 IA/bioinformatique

'It's going to create a revolution': how AI is transforming the NHS [The Guardian]